Preventing skin rash from incontinence in intensive care
Part of Skin clinical trials.
This study tests a new approach to preventing a common skin rash (incontinence-associated dermatitis) in ICU patients who have incontinence. If you qualify, the trial will help keep your skin healthy and comfortable while you’re in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be in an intensive care unit (ICU) and have been incontinent (leaking urine or stool) for at least 2 days.
- You must be at high risk for a skin problem called incontinence-associated dermatitis (IAD), which is a painful rash caused by moisture and irritants from urine or stool.
- You must be able to give your consent, or have a guardian or witness help with the consent process if needed.
- You cannot already have IAD, and the areas of skin involved must be free from breaks or infections.
- You must not be using certain products like diapers or incontinence pads, and must be able to move into a side-lying position.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new protective cream for a rash caused by diarrhea or stool leakage. The cream is meant to soothe and protect your skin in that area, potentially helping it heal and stay comfortable.
This trial tests a new barrier cream to treat skin irritation caused by diarrhea or stool leakage. It aims to see if the cream is safe and helps heal the skin better than standard care.
This trial tests a new skin protectant lotion for people in the hospital with skin damage from moisture (like urine or stool). It aims to see if the lotion helps heal these wounds better than current care.
This trial is testing whether a special medical adhesive and protective barrier can reduce skin damage (MARSI) from the dressing used to hold a central line in place. It is for adults in intensive care or the operating room who are getting a central line in their neck.
This study tests a special dressing to help prevent pressure sores on the lower back and tailbone area while you are in the hospital's intensive care unit. It aims to see if this dressing reduces the risk of developing these sores.
This study tests whether a special cream containing beta-glucan (a natural ingredient) can soothe and protect skin damaged by urine or stool leakage. You'd apply the cream during a hospital stay of at least one week to see if it helps healing.
Hear when a new Incontinence Associated Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.